AceView: Gene:MSI2, a comprehensive annotation of human, mouse and worm genes with mRNAs or ESTsAceView.

cDNA accession Links to the sequence	Tissue most 5' clones in red	Match mRNA	From bp to bp in mRNA	From bp to bp in accs.	Clone encodes complete protein (with AA variation)	Features	Anomalies detected by AceView	Accession match over (% length)	Base differences relative to genome (% identity)
AF034182		.b	1691 to 1925	165 to 401				237/402 (58 %)	8 diff (98.1 %id)
Z28675	leg muscle, skeletal muscle	.b	3133 to 3282	1 to 150		AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	150/150 (100 %)	2 diff (98.7 %id)
AA249587		.b	1736 to 1907	1 to 173				173/173 (100 %)	3 diff (98.3 %id)
AA305490	colon	.b	1026 to 1389	1 to 364				364/364 (100 %)	4 diff (99.0 %id)
AA314716	colon	.b	523 to 711	282 to 470				189/470 (40 %)	6 diff (98.8 %id)
AA372628	colon	.a	209 to 538	1 to 330				330/330 (100 %)	0 diff (100 %id)
AV707089	adrenal gland	.b	2484 to 3180	1 to 695				695/695 (100 %)	6 diff (99.2 %id)
AI207633	Liver	.n	11 to 530	1 to 520		AAA	Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base)	520/520 (100 %)	0 diff (100 %id)
AK093888	trachea	.f	1 to 1859	2 to 1860	exact	tiling clone, available from FLJ,		1860/1860 (100 %)	3 diff (99.9 %id)
AK128251	thymus	.g-u	2773 to 6443	1 to 3671		tiling clone, available from FLJ,		3671/3671 (100 %)	2 diff (100.0 %id)
AK295060	brain	.b	1 to 1715	1 to 1715	exact	tiling clone,		1715/1715 (100 %)	2 diff (99.9 %id)
AK297295	brain	.c	268 to 1740	152 to 1625		tiling clone,		1474/1625 (90 %)	11 diff (99.4 %id)
AL833068	human spinal cord	.i-u	1 to 6625	1 to 6623	exact	tiling clone, available from DKFZ, AAA	Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base)	6623/6623 (100 %)	23 diff (99.7 %id)
AW377687	colon	.b	2851 to 3037	1 to 188				188/188 (100 %)	1 diff (99.5 %id)
AW605404	denis_drash	.b	1012 to 1397	1 to 382				382/384 (99 %)	13 diff (96.7 %id)
AW805112	uterus	.i-u	5121 to 5293	1 to 171		tiling clone,		171/174 (98 %)	6 diff (96.6 %id)
AW856237	colon	.i-u	5300 to 5767	1 to 465				465/475 (97 %)	10 diff (97.9 %id)
AW864084	stomach_normal	.b	1610 to 2181	6 to 577				572/577 (99 %)	6 diff (99.0 %id)
AW864154	stomach_normal	.b	1591 to 2182	10 to 600				591/613 (96 %)	13 diff (97.9 %id)
AW864164	stomach_normal	.b	1600 to 2146	1 to 545				545/546 (99 %)	12 diff (97.9 %id)
AW896090	nervous_normal	.k	440 to 802	524 to 162		tiling clone,		363/537 (67 %)	0 diff (100 %id)
AW903305	nervous_normal	.q	1956 to 2287	10 to 341		tiling clone,		332/346 (95 %)	1 diff (99.8 %id)
AW960441		.b	1034 to 1671	1 to 636				636/636 (100 %)	8 diff (98.8 %id)
AW969154		.q	4454 to 5128	670 to 1			Submitted on the opposite strand	670/670 (100 %)	10 diff (98.6 %id)
AX748353		.f	1 to 1859	2 to 1860	exact			1860/1860 (100 %)	3 diff (99.9 %id)
BC001526	Placenta, choriocarcinoma	.a	1 to 1396	1 to 1396	exact	tiling clone, available from MGC, AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	1396/1396 (100 %)	1 diff (100.0 %id)
BE000929	breast_normal	.g-u	6918 to 7537	634 to 16			Submitted on the opposite strand	619/634 (97 %)	0 diff (100 %id)
BE002675	breast_normal	.t-u	1413 to 1924	514 to 5		tiling clone,	Submitted on the opposite strand	510/514 (99 %)	0 diff (100 %id)
BE010977	breast_normal	.t-u	1 to 328	328 to 1		tiling clone,	Submitted on the opposite strand	328/328 (100 %)	0 diff (100 %id)
BE697796	colon	.b	2077 to 2488	19 to 427				409/427 (95 %)	6 diff (98.6 %id)
BE697804	colon	.b	2073 to 2488	1 to 413				413/413 (100 %)	5 diff (98.8 %id)
BE836557	prostate_normal	.c	1049 to 1381	345 to 13				333/345 (96 %)	0 diff (100 %id)
BE836562	prostate_normal	.c	1051 to 1381	343 to 13				331/343 (96 %)	0 diff (100 %id)
BE939700	uterus_tumor	.k	125 to 447	334 to 12				323/334 (96 %)	0 diff (100 %id)
BF091631	testis_normal	.g-u	7191 to 7466	1 to 274				274/332 (82 %)	12 diff (96.4 %id)
BF155165	breast	.vb-u	1 to 440	29 to 465	exact	tiling clone,		437/486 (89 %)	5 diff (99.0 %id)
BF172685	blood	.b	1077 to 1344	1 to 271				271/271 (100 %)	5 diff (98.2 %id)
BF333115	breast	.g-u	5218 to 5596	1 to 375				375/375 (100 %)	7 diff (98.2 %id)
BF366011	nervous_tumor	.g-u	1479 to 1826	1 to 347				347/347 (100 %)	10 diff (97.2 %id)
BF366012	nervous_tumor	.g-u	1546 to 1941	1 to 398				398/400 (99 %)	9 diff (97.8 %id)
BF366014	nervous_tumor	.g-u	1470 to 1942	1 to 476				476/487 (97 %)	5 diff (99.0 %id)
BF366017	nervous_tumor	.i-u	5389 to 5775	1 to 387		tiling clone,		387/387 (100 %)	10 diff (97.5 %id)
BF366019	nervous_tumor	.g-u	1474 to 1826	14 to 366				353/366 (96 %)	6 diff (98.4 %id)
BF812760	colon_ins	.q	4127 to 4349	1 to 219				219/219 (100 %)	8 diff (96.4 %id)
BF838380	head_neck	.k	1 to 481	15 to 497	G2V G3R L4H S5E W6L ...	tiling clone,		483/499 (96 %)	14 diff (97.2 %id)
BF884520	lung_tumor	.q	4592 to 4912	332 to 14			Submitted on the opposite strand	319/332 (96 %)	0 diff (100 %id)
BF929115	nervous_tumor	.g-u	7266 to 7686	1 to 421				421/425 (99 %)	16 diff (96.3 %id)
BF955385	nervous_normal	.i-u	436 to 905	470 to 1				470/470 (100 %)	1 diff (99.8 %id)
BF956321	nervous_normal	.t-u	3798 to 4040	32 to 273				242/273 (88 %)	6 diff (97.9 %id)
BF956323	nervous_normal	.t-u	3901 to 4109	343 to 135				209/343 (60 %)	0 diff (100 %id)
BG007627	placenta_normal	.g-u	973 to 1410	1 to 439				439/439 (100 %)	4 diff (99.1 %id)
BG953430	colon	.i-u	5091 to 5283	1 to 194				194/212 (91 %)	11 diff (94.9 %id)
BG991535	head_neck	.ve-u	1 to 222	224 to 2	exact	tiling clone,		223/224 (99 %)	0 diff (100 %id)
BI029856	marrow	.i-u	3521 to 3950	1 to 429				429/436 (98 %)	7 diff (98.4 %id)
BI032746	nervous_normal	.q	4669 to 4947	1 to 279				279/279 (100 %)	3 diff (99.0 %id)
BI033139	nervous_normal	.q	4613 to 4947	1 to 332				332/332 (100 %)	9 diff (97.3 %id)
BI034212	nervous_normal	.q	4650 to 4841	17 to 206				190/222 (85 %)	11 diff (95.1 %id)
BM264417	Pancreas, Purified pancreatic islet	.b	2913 to 3408	496 to 1				496/496 (100 %)	0 diff (100 %id)
BM271776	Pancreas, Purified pancreatic islet	.b	2387 to 2899	11 to 524				514/524 (98 %)	6 diff (98.9 %id)
BM353635	Pancreas, Purified pancreatic islet	.b	2863 to 3408	546 to 1				546/546 (100 %)	0 diff (100 %id)
BM353913	Pancreas, Purified pancreatic islet	.b	2386 to 2983	10 to 607				598/607 (98 %)	6 diff (99.1 %id)
BM509418	insulinoma, Pancreas	.g-u	7168 to 7610	445 to 2			Submitted on the opposite strand	444/445 (99 %)	0 diff (100 %id)
DA066244	cerebellum	.f	418 to 943	43 to 568		capped		526/567 (92 %)	5 diff (99.2 %id)
DB297291	cerebellum	.f	1684 to 2141	458 to 1				458/461 (99 %)	1 diff (99.8 %id)
DA089808	cerebellum	.h	1 to 696	2 to 575	D143R S144R P145R T146M P147A ...	tiling clone, capped	Suspected internal deletion	574/574 (100 %)	0 diff (100 %id)
DA124347	cerebellum	.t-u	728 to 1264	2 to 539		tiling clone, capped		538/538 (100 %)	2 diff (99.7 %id)
DB300704	cerebellum	.t-u	3939 to 4405	467 to 1				467/467 (100 %)	17 diff (96.4 %id)
DA131289	alzheimer cortex	.f	333 to 865	38 to 571		capped		534/570 (93 %)	6 diff (99.0 %id)
DA162975	amygdala	.a	120 to 588	2 to 470		capped		469/589 (79 %)	6 diff (99.0 %id)
DC324151	brain	.b	1 to 485	1 to 485				485/580 (83 %)	7 diff (98.8 %id)
DA259617	caudate nucleus	.a	77 to 588	2 to 513		capped		512/577 (88 %)	7 diff (98.8 %id)
DA361298	subthalamic nucleus	.u	1 to 547	2 to 548	exact	tiling clone, capped		547/547 (100 %)	1 diff (99.9 %id)
BX095130	melanocyte	.b	1886 to 2454	11 to 580		tiling clone,		570/580 (98 %)	5 diff (99.2 %id)
BX114190	liver and spleen	.q	4545 to 5136	590 to 1			Submitted on the opposite strand	590/590 (100 %)	4 diff (99.4 %id)
BX119204	pooled germ cell tumors	.a	205 to 588	1 to 384				384/496 (77 %)	6 diff (98.8 %id)
BX282070	melanotic melanoma, skin	.b	466 to 956	10 to 501				492/501 (98 %)	6 diff (98.9 %id)
BX647282	human retina	.q	1 to 5122	1 to 5122	exact	tiling clone, available from DKFZ, AAA	Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base)	5122/5122 (100 %)	6 diff (99.9 %id)
BX647939	human testis	.g-u	1 to 7611	1 to 7611	exact	tiling clone, available from DKFZ, AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	7611/7611 (100 %)	8 diff (99.9 %id)
C03706	heart	.b	2388 to 2802	1 to 415				415/415 (100 %)	7 diff (98.4 %id)
CD237302	Pituitary	.b	2485 to 3196	1 to 711				711/711 (100 %)	9 diff (98.8 %id)
CD636577		.a	890 to 1441	1 to 552				552/552 (100 %)	10 diff (98.2 %id)
CD636578		.a	896 to 1441	548 to 1				548/555 (98 %)	3 diff (99.5 %id)
CN274644	embryonic stem cells, DMSO-treated H9 cellline	.a	127 to 588	1 to 462				462/660 (70 %)	6 diff (99.1 %id)
CN290427	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	.b	2415 to 3012	1 to 598				598/598 (100 %)	0 diff (100 %id)
CN370693	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	.b	2431 to 3164	1 to 735				735/735 (100 %)	2 diff (99.8 %id)
CN370694	embryonic stem cells, cell lines H1, H7, andH9	.b	2983 to 3365	1 to 383				383/383 (100 %)	1 diff (99.8 %id)
CR739002	anaplastic oligodendroglioma, brain	.n	21 to 488	1 to 469				469/469 (100 %)	1 diff (99.8 %id)
CR743213	Prostate	.b	2162 to 2628	1 to 467				467/469 (99 %)	1 diff (99.8 %id)
BX437573	thymus	.c	2288 to 3236	951 to 1		tiling clone,		951/951 (100 %)	5 diff (99.5 %id)
BX437574	thymus	.c	546 to 1423	1 to 878		tiling clone,		878/878 (100 %)	3 diff (99.7 %id)
BX441848	brain, fetal brain	.b	2404 to 2920	1 to 520				520/521 (99 %)	6 diff (98.9 %id)
BX452101	brain, fetal brain	.b	2785 to 3292	1 to 514				514/635 (80 %)	31 diff (95.2 %id)
DA454867	tongue, tumor tissue	.r	1 to 501	2 to 502	F55S	tiling clone, capped		501/501 (100 %)	2 diff (99.7 %id)
CV027635	mixed	.a	174 to 804	1 to 631				631/631 (100 %)	1 diff (99.9 %id)
CV384246	nervous_tumor	.vc-u	1 to 422	1 to 428	A2P L4V A12*	tiling clone,		428/428 (100 %)	30 diff (93.0 %id)
BX486517		.b	2497 to 3126	1 to 630				630/630 (100 %)	3 diff (99.6 %id)
BX493432		.b	3610 to 4174	1 to 566		tiling clone,		566/566 (100 %)	2 diff (99.7 %id)
BX642669		.q	913 to 1531	1 to 619		tiling clone,		619/619 (100 %)	1 diff (99.9 %id)
DW428745	Liver	.e	977 to 1183	17 to 222		tiling clone, AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	206/222 (92 %)	6 diff (97.3 %id)
DW431283	Liver	.g-u	5758 to 6010	17 to 269				253/269 (94 %)	6 diff (97.8 %id)
DW431598	Liver	.b	439 to 697	10 to 268				259/268 (96 %)	7 diff (97.4 %id)
DW452791	Liver	.e	977 to 1151	17 to 190				174/190 (91 %)	6 diff (96.9 %id)
EL737187	mixed	.f	335 to 789	1 to 455				455/621 (73 %)	0 diff (100 %id)
DC350824	brain	.b	365 to 788	152 to 575				424/575 (73 %)	6 diff (99.0 %id)
FN081272	breast carcinoma	.b	2749 to 2818	1 to 70				70/71 (98 %)	1 diff (98.6 %id)
FN088298	breast carcinoma	.b	2680 to 2754	76 to 1			Submitted on the opposite strand	76/77 (98 %)	1 diff (98.8 %id)
FN105568	breast carcinoma	.b	2995 to 3074	80 to 3			Submitted on the opposite strand	78/94 (82 %)	0 diff (100 %id)
FN112149	breast carcinoma	.b	1817 to 1934	125 to 12			Submitted on the opposite strand	114/125 (91 %)	0 diff (100 %id)
FN121172	breast carcinoma	.b	2957 to 3068	109 to 1			Submitted on the opposite strand	109/109 (100 %)	5 diff (95.5 %id)
FN130904	breast carcinoma	.vf-u	1 to 126	1 to 129	A18S L19F F20V R21*	tiling clone,		129/129 (100 %)	3 diff (97.7 %id)
FN147378	breast carcinoma	.b	2865 to 2926	61 to 1			Submitted on the opposite strand	61/61 (100 %)	1 diff (98.4 %id)
FN149643	breast carcinoma	.b	3024 to 3104	82 to 1			Submitted on the opposite strand	82/83 (98 %)	1 diff (98.8 %id)
GD135974		.q	5083 to 5143	1 to 61				61/63 (96 %)	3 diff (95.3 %id)
GD136674		.b	2933 to 3122	190 to 1			Submitted on the opposite strand	190/191 (99 %)	3 diff (98.5 %id)
GD136970		.b	2933 to 3122	190 to 1			Submitted on the opposite strand	190/191 (99 %)	3 diff (98.5 %id)
GD138449		.b	2936 to 3118	188 to 6		AAA	Submitted on the opposite strand	183/188 (97 %)	0 diff (100 %id)
GD146334		.b	2940 to 3115	181 to 6		AAA	Submitted on the opposite strand	176/185 (95 %)	0 diff (100 %id)
GD146345		.b	2936 to 3112	186 to 10			Submitted on the opposite strand	177/186 (95 %)	0 diff (100 %id)
GD148177		.i-u	6175 to 6333	1 to 159				159/163 (97 %)	5 diff (97.0 %id)
GD153040		.b	2602 to 2761	163 to 1		AAA	Submitted on the opposite strand	163/165 (98 %)	6 diff (96.4 %id)
GD153044		.b	2602 to 2761	160 to 1			Submitted on the opposite strand	160/167 (95 %)	2 diff (98.9 %id)
GD158516		.q	5083 to 5143	1 to 61				61/64 (95 %)	2 diff (96.9 %id)
AV682762	hepatocellular carcinoma	.b	2523 to 3180	1 to 658				658/658 (100 %)	1 diff (99.9 %id)
BQ638186	eye, retina	.g-u	5697 to 6341	1 to 645		tiling clone,		645/645 (100 %)	0 diff (100 %id)
DA572432	whole embryo, mainly body	.f	432 to 1274	2 to 840		capped		839/848 (98 %)	14 diff (98.4 %id)
DB359450	whole embryo, mainly body	.f	1602 to 2141	542 to 1		tiling clone,		542/543 (99 %)	12 diff (97.8 %id)
BP422325	small intestine	.b	2902 to 3423	522 to 1				522/522 (100 %)	1 diff (99.9 %id)
DA583392	lung	.g-u	3503 to 4048	2 to 547		capped		546/546 (100 %)	2 diff (99.7 %id)
DB319298	lung	.g-u	5893 to 6443	551 to 1				551/551 (100 %)	0 diff (100 %id)
AV728112	hypothalamus	.c	1050 to 1780	1 to 730				730/730 (100 %)	26 diff (96.5 %id)
H90188	liver and spleen	.q	4750 to 5135	392 to 2			Submitted on the opposite strand	391/399 (97 %)	0 diff (100 %id)
H90847	liver and spleen	.q	4466 to 4822	1 to 364			Submitted on the opposite strand	364/367 (99 %)	18 diff (95.1 %id)
N52994	liver and spleen	.b	2731 to 3177	447 to 1				447/447 (100 %)	3 diff (99.4 %id)
H96502	melanocyte	.b	2934 to 3416	486 to 1				486/488 (99 %)	7 diff (98.6 %id)
H96971	melanocyte	.b	1492 to 1928	438 to 1				438/438 (100 %)	3 diff (99.4 %id)
N20665	melanocyte	.c	1452 to 1777	328 to 1		fully sequenced,		328/328 (100 %)	2 diff (99.4 %id)
N29042	melanocyte	.c	1132 to 1482	1 to 359		fully sequenced,		359/359 (100 %)	2 diff (99.5 %id)
N66818	melanocyte	.b	2967 to 3399	443 to 10				434/443 (97 %)	0 diff (100 %id)
W56402	melanocyte	.b	1913 to 2508	1 to 597				597/597 (100 %)	13 diff (97.9 %id)
AA063071	pineal gland	.g-u	7525 to 7730	1 to 206		tiling clone,	Submitted on the opposite strand	206/207 (99 %)	1 diff (99.6 %id)
AA195719	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.b	3018 to 3408	392 to 2				391/392 (99 %)	0 diff (100 %id)
AA195755	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.b	1916 to 2330	1 to 416				416/416 (100 %)	1 diff (99.8 %id)
AA227975	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.b	1895 to 2240	346 to 1				346/346 (100 %)	2 diff (99.5 %id)
AA228139	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.b	611 to 1029	1 to 404				407/404 (100 %)	26 diff (93.6 %id)
AA235112	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.c	1525 to 1778	254 to 1				254/254 (100 %)	1 diff (99.7 %id)
AA235221	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.c	1132 to 1523	1 to 391				391/391 (100 %)	5 diff (98.8 %id)
AA425281		.b	3314 to 3760	447 to 1				447/447 (100 %)	0 diff (100 %id)
AA425483		.b	2850 to 3304	1 to 454				454/454 (100 %)	2 diff (99.6 %id)
AA428576		.q	4762 to 5132	371 to 1				371/371 (100 %)	3 diff (99.2 %id)
AA429532		.q	4188 to 4639	1 to 452		tiling clone,		452/452 (100 %)	2 diff (99.6 %id)
AA521410	germinal center B cell	.q	4552 to 5138	582 to 1				582/582 (100 %)	10 diff (98.3 %id)
AA521327	germinal center B cell	.q	4632 to 5138	508 to 1				508/508 (100 %)	9 diff (98.3 %id)
AA468538	colon	.b	2993 to 3414	421 to 1				421/421 (100 %)	1 diff (99.8 %id)
AA774921	schizophrenic brain S-11 frontal lobe	.t-u	3769 to 3912	1 to 144		tiling clone,	Submitted on the opposite strand	144/144 (100 %)	1 diff (99.4 %id)
AA552985	Schwannoma tumor	.e	475 to 1185	710 to 1		tiling clone,		710/710 (100 %)	7 diff (99.1 %id)
AA807495	germinal center B cell	.b	2969 to 3426	458 to 1				458/458 (100 %)	7 diff (98.5 %id)
AA738321	pooled germ cell tumors	.b	2507 to 2712	245 to 40		AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	206/206 (100 %)	1 diff (99.6 %id)
AA743713	germinal center B cell	.b	2736 to 3169	441 to 9				433/441 (98 %)	0 diff (100 %id)
AA814267	germinal center B cell	.b	2987 to 3426	438 to 1				438/438 (100 %)	5 diff (98.9 %id)
AA765939	germinal center B cell	.b	946 to 1347	417 to 16		AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	402/412 (97 %)	3 diff (99.3 %id)
AA724751	pooled	.b	3056 to 3413	358 to 1				358/358 (100 %)	7 diff (98.1 %id)
AA837252	germinal center B cell	.b	3058 to 3422	362 to 1				362/362 (100 %)	2 diff (99.5 %id)
AA836389	germinal center B cell	.b	936 to 1350	432 to 19		AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	414/415 (99 %)	5 diff (98.8 %id)
AA843302	parathyroid gland, parathyroid tumor	.b	3117 to 3421	306 to 1				306/306 (100 %)	1 diff (99.7 %id)
AI184868	pooled	.b	2262 to 2686	425 to 1				425/425 (100 %)	0 diff (100 %id)
AA960952	carcinoid, lung	.b	3027 to 3333	1 to 308			Submitted on the opposite strand	308/308 (100 %)	9 diff (97.1 %id)
AA948284	pooled germ cell tumors	.b	2287 to 2712	424 to 1				424/424 (100 %)	1 diff (99.8 %id)
AI023422	liver and spleen	.t-u	1399 to 1850	463 to 12		AAA		452/452 (100 %)	0 diff (100 %id)
AI049958		.b	2890 to 3413	539 to 16		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	524/524 (100 %)	1 diff (99.9 %id)
AI139567	placenta	.b	2261 to 2724	470 to 8				463/470 (98 %)	0 diff (100 %id)
AI215489	pooled	.b	2773 to 3168	396 to 1				396/396 (100 %)	1 diff (99.8 %id)
AI269890	Kidney	.b	2912 to 3408	501 to 4				498/501 (99 %)	0 diff (100 %id)
AI300846	2 pooled tumors (clear cell type), Kidney	.b	1049 to 1350	315 to 14		AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	302/302 (100 %)	0 diff (100 %id)
AI202531	Prostate	.b	2272 to 2678	406 to 1				406/406 (100 %)	4 diff (99.1 %id)
AI367974	moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus	.b	3056 to 3408	355 to 3				353/355 (99 %)	5 diff (98.6 %id)
AI369752	anaplastic oligodendroglioma, brain	.g-u	7222 to 7612	391 to 1				391/391 (100 %)	1 diff (99.8 %id)
AI493004	Kidney	.b	2934 to 3408	475 to 1				475/475 (100 %)	0 diff (100 %id)
AI309570	2 pooled tumors (clear cell type), Kidney	.b	1059 to 1351	299 to 7				293/299 (97 %)	0 diff (100 %id)
AI803606	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.n	426 to 933	508 to 1		tiling clone,		508/508 (100 %)	0 diff (100 %id)
AI420567	Prostate	.b	2343 to 2678	335 to 1				335/335 (100 %)	5 diff (98.6 %id)
AI468178	Prostate	.b	2502 to 2678	178 to 1				178/178 (100 %)	1 diff (99.5 %id)
AI399898	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.b	1508 to 1927	421 to 1				421/421 (100 %)	3 diff (99.3 %id)
AI473254	Kidney	.n	381 to 523	151 to 9				143/151 (94 %)	0 diff (100 %id)
AI439153	Kidney	.b	2896 to 3413	519 to 1				519/519 (100 %)	2 diff (99.7 %id)
AI446696	poorly differentiated adenocarcinoma withsignet ring cell features, stomach	.a	906 to 1373	23 to 490			Submitted on the opposite strand	468/490 (95 %)	10 diff (98.0 %id)
AI802948	pooled	.a	766 to 1400	639 to 4				636/643 (98 %)	15 diff (97.7 %id)
AI470018	pooled	.b	2673 to 3153	1 to 481			Submitted on the opposite strand	481/481 (100 %)	1 diff (99.8 %id)
AI498424	Kidney	.b	2640 to 2925	286 to 1				286/286 (100 %)	0 diff (100 %id)
AI498100	anaplastic oligodendroglioma, brain	.n	99 to 530	461 to 29		AAA	Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base)	433/497 (87 %)	18 diff (96.4 %id)
AI572440	anaplastic oligodendroglioma, brain	.g-u	7314 to 7612	307 to 9				299/307 (97 %)	0 diff (100 %id)
AI632140	pooled germ cell tumors	.b	3152 to 3605	454 to 1				454/454 (100 %)	0 diff (100 %id)
AI638003	pooled germ cell tumors	.b	2911 to 3413	503 to 1				503/503 (100 %)	1 diff (99.9 %id)
AI686063	Prostate	.n	4 to 524	529 to 9				521/529 (98 %)	1 diff (99.9 %id)
AI802169	carcinoid, lung	.b	2988 to 3389	1 to 402			Submitted on the opposite strand	402/402 (100 %)	1 diff (99.8 %id)
AI802173	carcinoid, lung	.b	2599 to 3071	1 to 473			Submitted on the opposite strand	473/473 (100 %)	1 diff (99.8 %id)
AI758917	Kidney	.s	1 to 186	186 to 1	P61T	tiling clone,		186/186 (100 %)	2 diff (99.0 %id)
AI872274	ovary, tumor, 5 pooled (see description)	.b	2513 to 2926	417 to 4				414/417 (99 %)	0 diff (100 %id)
AI913722	Kidney	.b	2948 to 3413	466 to 1				466/466 (100 %)	0 diff (100 %id)
AI640458	Kidney	.b	3061 to 3413	353 to 1				353/353 (100 %)	0 diff (100 %id)
AI653310	pooled germ cell tumors	.b	2235 to 2712	478 to 1				478/478 (100 %)	3 diff (99.4 %id)
AI650679	pooled germ cell tumors	.g-u	6851 to 7333	483 to 1				483/483 (100 %)	2 diff (99.6 %id)
AI678168	Prostate	.b	3021 to 3413	393 to 1				393/393 (100 %)	4 diff (99.0 %id)
AI674728	pooled	.b	2070 to 2531	469 to 8				462/469 (98 %)	0 diff (100 %id)
AI694538	carcinoid, lung	.g-u	6544 to 7078	21 to 552			Submitted on the opposite strand	532/552 (96 %)	6 diff (99.0 %id)
AI693351	carcinoid, lung	.b	2837 to 3293	1 to 457			Submitted on the opposite strand	457/457 (100 %)	0 diff (100 %id)
AI697764	carcinoid, lung	.b	2979 to 3382	1 to 404			Submitted on the opposite strand	404/404 (100 %)	4 diff (99.1 %id)
AI694944	carcinoid, lung	.b	2489 to 2966	488 to 11		AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	478/478 (100 %)	0 diff (100 %id)
AI695483	colon	.b	2380 to 2713	342 to 5				338/342 (98 %)	0 diff (100 %id)
AI798817	pooled	.g-u	7308 to 7612	313 to 9				305/313 (97 %)	0 diff (100 %id)
AI741465	pooled	.b	2941 to 3411	491 to 21		AAA	Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base)	471/471 (100 %)	1 diff (99.8 %id)
AI761626	pooled	.b	2850 to 3420	572 to 1				572/572 (100 %)	9 diff (98.5 %id)
AI808923	B-cell, chronic lymphotic leukemia	.b	3019 to 3397	391 to 13				379/391 (96 %)	0 diff (100 %id)
AI769454	2 pooled tumors (clear cell type), Kidney	.b	2781 to 3417	637 to 1				637/637 (100 %)	1 diff (99.9 %id)
AI862535	2 pooled tumors (clear cell type), Kidney	.b	2233 to 2713	484 to 4				481/484 (99 %)	0 diff (100 %id)
AI819588	lymph node, lymphoma, follicular mixed small and largecell	.b	2654 to 2855	11 to 210			Submitted on the opposite strand	200/210 (95 %)	6 diff (97.2 %id)
AI922376	uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors	.b	2893 to 3287	420 to 24		AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	397/397 (100 %)	18 diff (95.5 %id)
AI933313	anaplastic oligodendroglioma, brain	.n	115 to 537	424 to 1				424/424 (100 %)	2 diff (99.6 %id)
AI937290	anaplastic oligodendroglioma, brain	.b	3019 to 3414	398 to 1				398/398 (100 %)	15 diff (96.3 %id)
AI937363	anaplastic oligodendroglioma, brain	.b	2946 to 3414	469 to 1				469/469 (100 %)	3 diff (99.4 %id)
AI970795	normal prostate, Prostate	.b	2223 to 2678	456 to 1				456/456 (100 %)	2 diff (99.6 %id)
AI971282	Prostate	.n	1 to 521	536 to 9	I92N D93*	tiling clone, AAA	Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base)	525/525 (100 %)	4 diff (99.3 %id)
AI972510	Prostate	.b	2198 to 2678	481 to 1				481/481 (100 %)	2 diff (99.6 %id)
AI972781	Prostate	.b	2232 to 2678	447 to 1				447/447 (100 %)	0 diff (100 %id)
AI992362	pooled germ cell tumors	.b	2235 to 2712	474 to 1				474/477 (99 %)	10 diff (98.0 %id)
AW054806	anaplastic oligodendroglioma, brain	.a	190 to 486	297 to 1				297/298 (99 %)	8 diff (97.4 %id)
AW027784	Kidney	.n	82 to 535	454 to 1				454/454 (100 %)	0 diff (100 %id)
AW044428	pooled	.b	2268 to 2718	455 to 5		tiling clone,		451/455 (99 %)	0 diff (100 %id)
AW078936	2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney	.b	3077 to 3413	351 to 15		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	337/339 (99 %)	1 diff (99.8 %id)
AW242504	Kidney	.b	2825 to 3232	408 to 1				408/408 (100 %)	6 diff (98.6 %id)
AW242693	Kidney	.b	2884 to 3399	524 to 7				518/524 (98 %)	0 diff (100 %id)
AW134658		.b	3017 to 3413	414 to 18		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	397/397 (100 %)	0 diff (100 %id)
AW137290		.b	2781 to 3168	405 to 18		AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	388/388 (100 %)	1 diff (99.8 %id)
AW204863		.b	3025 to 3422	398 to 1				398/398 (100 %)	0 diff (100 %id)
AW291624		.b	2254 to 2682	443 to 15		AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	429/429 (100 %)	0 diff (100 %id)
AW292246		.b	2462 to 2712	268 to 18		AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	251/251 (100 %)	3 diff (98.9 %id)
AW270384	endometrioid ovarian metastasis, ovary	.q	4479 to 4888	9 to 418			Submitted on the opposite strand	410/418 (98 %)	6 diff (98.6 %id)
AW250196	lung, small cell carcinoma	.g-u	7080 to 7611	542 to 11		tiling clone, AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	532/532 (100 %)	0 diff (100 %id)
AW470320	carcinoid, lung	.b	2699 to 3169	471 to 1				471/471 (100 %)	1 diff (99.8 %id)
AW593486	pooled germ cell tumors	.b	2232 to 2712	481 to 1				481/481 (100 %)	1 diff (99.8 %id)
AW590496	pooled germ cell tumors	.b	2390 to 2708	323 to 5				319/323 (98 %)	0 diff (100 %id)
AW769700	2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney	.b	3076 to 3425	355 to 1				355/355 (100 %)	8 diff (97.8 %id)
AW405813. matches multiple genes	lymph	.b	2098 to 2367	8 to 277			also hits gene IFITM1	270/277 (97 %)	6 diff (97.9 %id)
BF197320	Kidney	.b	3132 to 3408	277 to 1				277/277 (100 %)	0 diff (100 %id)
BE219279	carcinoid, lung	.b	2655 to 3169	515 to 1				515/519 (99 %)	1 diff (99.9 %id)
BE219853	carcinoid, lung	.b	2717 to 3169	453 to 1				453/453 (100 %)	2 diff (99.6 %id)
BE220026	carcinoid, lung	.b	2616 to 3169	553 to 1				553/553 (100 %)	2 diff (99.7 %id)
BE220408	carcinoid, lung	.b	2410 to 2713	304 to 1				304/304 (100 %)	0 diff (100 %id)
BE327252	carcinoid, lung	.b	944 to 1211	1 to 269			Submitted on the opposite strand	269/269 (100 %)	6 diff (97.8 %id)
BE467574	carcinoid, lung	.b	2949 to 3388	1 to 440			Submitted on the opposite strand	440/440 (100 %)	3 diff (99.4 %id)
CB046649	2 pooled tumors (clear cell type), Kidney	.c	2315 to 2760	506 to 61		tiling clone, AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	446/453 (98 %)	6 diff (98.7 %id)
CB046650	2 pooled tumors (clear cell type), Kidney	.c	943 to 1201	17 to 275			Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	259/275 (94 %)	6 diff (97.9 %id)
BF589094	pooled	.b	2371 to 2713	349 to 7				343/349 (98 %)	0 diff (100 %id)
BF435123	pooled	.b	2185 to 2685	501 to 1				501/501 (100 %)	0 diff (100 %id)
BF439690	pooled	.b	2719 to 3280	566 to 5				562/566 (99 %)	0 diff (100 %id)
BE670921	carcinoid, lung	.b	2294 to 2713	423 to 4				420/423 (99 %)	0 diff (100 %id)
BE646217	Prostate	.b	2221 to 2678	458 to 1				458/458 (100 %)	0 diff (100 %id)
BE674916	B-cell, chronic lymphotic leukemia	.q	4662 to 5130	469 to 1				469/469 (100 %)	1 diff (99.8 %id)
BF002773	Prostate	.b	2297 to 2678	382 to 1				382/382 (100 %)	0 diff (100 %id)
BF448272	carcinoid, lung	.b	2668 to 3186	1 to 519			Submitted on the opposite strand	519/519 (100 %)	1 diff (99.9 %id)
BG149533	carcinoid, lung	.a	222 to 486	265 to 1				265/265 (100 %)	1 diff (99.7 %id)
BF055409	pooled	.b	2940 to 3419	480 to 1				480/480 (100 %)	6 diff (98.8 %id)
BE278791	choriocarcinoma, placenta	.a	21 to 485	1 to 469				469/699 (67 %)	7 diff (99.0 %id)
BF196671	brain, glioblastoma (pooled)	.b	2934 to 3413	480 to 1				480/480 (100 %)	0 diff (100 %id)
BF195264	carcinoid, lung	.b	2577 to 2966	390 to 1				390/390 (100 %)	2 diff (99.5 %id)
BF445988	breast, invasive ductal carcinoma, 3 pooled samples	.b	2940 to 3416	478 to 1				478/478 (100 %)	3 diff (99.4 %id)
BF446124	Prostate	.b	2296 to 2678	383 to 1				383/383 (100 %)	0 diff (100 %id)
BF446472	carcinoid, lung	.b	2980 to 3388	1 to 409			Submitted on the opposite strand	409/409 (100 %)	4 diff (99.1 %id)
BE872236	adenocarcinoma, colon	.b	2393 to 2923	1 to 532				532/532 (100 %)	9 diff (98.4 %id)
BE778519	eye, retinoblastoma	.b	632 to 1357	1 to 723				723/743 (97 %)	11 diff (98.6 %id)
BE891200	melanotic melanoma, skin	.b	2381 to 3059	3 to 680				678/690 (98 %)	6 diff (99.2 %id)
BC017560	Skin, melanotic melanoma.	.f	333 to 1859	104 to 1630		tiling clone, available from MGC, AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	1527/1630 (93 %)	6 diff (99.7 %id)
BE894256	melanotic melanoma, skin	.f	565 to 869	378 to 685		available from MGC,		308/808 (38 %)	16 diff (98.1 %id)
BE796433	lung, small cell carcinoma	.g-u	2164 to 2934	1 to 763				763/944 (80 %)	23 diff (97.6 %id)
BF029215	bladder, carcinoma, cell line	.n	121 to 523	1 to 402		AAA	Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base)	402/402 (100 %)	3 diff (99.3 %id)
BF345044	brain, glioblastoma with EGFR amplification	.b	2388 to 3032	1 to 642				642/642 (100 %)	11 diff (98.3 %id)
BF676261	Prostate	.q	3952 to 4456	1 to 512				512/871 (58 %)	17 diff (98.1 %id)
BF674723	Prostate	.i-u	1772 to 2402	1 to 639		tiling clone,		639/641 (99 %)	30 diff (95.4 %id)
BG223546	moderate to poorly differentiated invasivecarcinoma, tongue	.a	176 to 421	1 to 246				246/247 (99 %)	2 diff (99.2 %id)
BF797163	lymph, lymphoma, cell line	.b	2389 to 3084	1 to 705				705/965 (73 %)	14 diff (98.6 %id)
BG251844	adenocarcinoma, cell line, Liver	.b	2389 to 3105	12 to 719				708/722 (98 %)	15 diff (98.0 %id)
BG255522	adenocarcinoma, cell line, Prostate	.b	1780 to 2511	1 to 727				727/823 (88 %)	14 diff (98.3 %id)
BG261391	bladder, transitional cell papilloma, cell line	.b	2385 to 3176	1 to 785				785/785 (100 %)	13 diff (98.4 %id)
BI850917	bladder, transitional cell papilloma, cell line	.b	2385 to 3062	1 to 678				678/678 (100 %)	4 diff (99.5 %id)
BG282244	melanotic melanoma, skin	.a	101 to 485	1 to 384				384/911 (42 %)	4 diff (99.6 %id)
BG482956	lung	.b	2851 to 3033	1 to 187				187/223 (83 %)	12 diff (94.7 %id)
BG504030	embryonal carcinoma, testis	.b	2398 to 3132	1 to 727				727/768 (94 %)	28 diff (96.4 %id)
BG500195	adenocarcinoma, Prostate	.b	2705 to 3430	1 to 722				722/760 (95 %)	32 diff (95.8 %id)
BG537337	lung	.e	474 to 1080	1 to 603				603/604 (99 %)	31 diff (94.9 %id)
BG779658	adenocarcinoma, Prostate	.b	2237 to 2932	1 to 696				696/696 (100 %)	7 diff (99.0 %id)
BG745477	Spleen	.t-u	3011 to 3651	1 to 646		tiling clone, fully sequenced,		646/646 (100 %)	9 diff (98.7 %id)
BG745877	Spleen	.t-u	3621 to 4359	747 to 1		tiling clone, fully sequenced,		747/747 (100 %)	15 diff (98.0 %id)
BG912626	anaplastic oligodendroglioma with 1p/19qloss, brain	.t-u	1298 to 2105	1 to 807		tiling clone,		807/828 (97 %)	31 diff (96.3 %id)
BI223224	cervical carcinoma cell line, cervix	.b	2392 to 3170	1 to 805				805/817 (98 %)	69 diff (91.6 %id)
BM014815	breast, mammary adenocarcinoma, cell line	.b	615 to 966	1 to 353				353/356 (99 %)	2 diff (99.5 %id)
BQ270569	insulinoma, Pancreas	.n	7 to 541	538 to 2		tiling clone,		537/538 (99 %)	1 diff (99.9 %id)
BQ286271	Pancreas, Purified pancreatic islet	.b	2383 to 3026	6 to 648				643/648 (99 %)	6 diff (99.1 %id)
BQ416593	Pancreas, Purified pancreatic islet	.b	2924 to 3408	496 to 12		fully sequenced, AAA	Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base)	485/485 (100 %)	0 diff (100 %id)
BQ416897	Pancreas, Purified pancreatic islet	.b	2386 to 2950	16 to 580		fully sequenced,	Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base)	565/580 (97 %)	6 diff (99.0 %id)
BQ439249	embryonal carcinoma, cell line, testis	.b	3088 to 4172	12 to 1099		tiling clone,		1088/1101 (98 %)	40 diff (96.4 %id)
BU077970	Pancreas, Purified pancreatic islet	.b	2826 to 3398	584 to 11		fully sequenced,		574/584 (98 %)	1 diff (99.9 %id)
BU078217	Pancreas, Purified pancreatic islet	.b	2380 to 2856	3 to 480		fully sequenced,		478/480 (99 %)	6 diff (98.8 %id)
BU074622	Pancreas, Purified pancreatic islet	.b	2913 to 3408	497 to 3		fully sequenced,		495/497 (99 %)	6 diff (98.8 %id)
BU074911	Pancreas, Purified pancreatic islet	.b	2455 to 2943	1 to 489		fully sequenced,		489/489 (100 %)	0 diff (100 %id)
BQ432759	testis	.b	2588 to 3265	1 to 684				684/778 (87 %)	14 diff (98.3 %id)
BU786947	insulinoma, Pancreas	.b	933 to 1340	1 to 408			Submitted on the opposite strand	408/408 (100 %)	0 diff (100 %id)
BU781866	insulinoma, Pancreas	.b	2796 to 3422	634 to 8			Submitted on the opposite strand	627/634 (98 %)	0 diff (100 %id)
BU782780	insulinoma, Pancreas	.b	933 to 1582	1 to 651			Submitted on the opposite strand	651/651 (100 %)	1 diff (99.9 %id)
BU784022	insulinoma, Pancreas	.g-u	7023 to 7610	590 to 2			Submitted on the opposite strand	589/590 (99 %)	0 diff (100 %id)
BQ424010	eye, retinoblastoma	.b	2386 to 2925	1 to 540				540/766 (70 %)	8 diff (99.0 %id)
BQ431788	eye, retinoblastoma	.d	1 to 881	1 to 883	exact	tiling clone,		883/884 (99 %)	10 diff (98.9 %id)
BQ427484	melanotic melanoma, skin	.b	466 to 1265	8 to 809				802/862 (93 %)	8 diff (99.1 %id)
BQ708720	Spleen	.t-u	40 to 960	1 to 926	T62R L63*	tiling clone,		926/927 (99 %)	19 diff (98.0 %id)
BQ883933	Spleen	.t-u	40 to 931	1 to 897	G53R N67K L68F F69V Y70L ...			897/911 (98 %)	9 diff (99.1 %id)
BQ929543	leiomyosarcoma, uterus	.b	2386 to 3275	1 to 896				896/900 (99 %)	21 diff (97.7 %id)
BQ951490	leiomyosarcoma, uterus	.f	599 to 1510	1 to 917				917/922 (99 %)	16 diff (98.3 %id)
CA943839	Pancreas, Purified pancreatic islet	.b	3327 to 3408	82 to 1				82/82 (100 %)	0 diff (100 %id)
CA950034	Pancreas, Purified pancreatic islet	.b	2386 to 2992	11 to 617				607/617 (98 %)	6 diff (99.1 %id)
BU852870	testis	.b	2644 to 3409	1 to 777		tiling clone,		777/786 (98 %)	22 diff (97.3 %id)
BU857812	adenocarcinoma, cell line, breast	.c	1 to 770	1 to 772		tiling clone,		772/945 (81 %)	8 diff (99.2 %id)
BU956254	adenocarcinoma, cell line, breast	.u	317 to 939	127 to 753	exact	tiling clone,		627/1025 (61 %)	17 diff (98.4 %id)
BU956366	adenocarcinoma, cell line, breast	.n	5 to 532	1 to 528				528/536 (98 %)	1 diff (99.9 %id)
BU957799	mixed (pool of 40 RNAs)	.b	3115 to 3449	1 to 335				335/335 (100 %)	11 diff (96.8 %id)
CV803181	Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass	.a	185 to 894	1 to 703				703/837 (83 %)	8 diff (99.1 %id)
CX758846	Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass	.a	98 to 485	1 to 388			Submitted on the opposite strand	388/779 (49 %)	4 diff (99.5 %id)
CB990972	placenta, pre-eclamptic placenta	.b	2369 to 2884	27 to 549				523/912 (57 %)	40 diff (95.7 %id)
TI_59392879		.b	615 to 966	91 to 443				353/356 (99 %)	2 diff (99.5 %id)
N84905		.b	1125 to 1335	1 to 212				212/212 (100 %)	3 diff (98.6 %id)
CB135005	Liver	.b	2404 to 2948	1 to 545				545/545 (100 %)	1 diff (99.9 %id)
DA655331		.a	87 to 588	2 to 503		capped		502/553 (90 %)	6 diff (99.0 %id)
EB387209	eye, optic nerve	.c	1201 to 2038	1 to 839		tiling clone,		839/839 (100 %)	2 diff (99.8 %id)
EB388130	eye, optic nerve	.t-u	918 to 1666	1 to 748		tiling clone,		748/748 (100 %)	3 diff (99.6 %id)
NM_138962.2		.a	1 to 1581	1 to 1581	exact	RefSeq,		1581/1581 (100 %)	0 diff (100 %id)
NM_170721.1		.f	1 to 2149	2 to 2150	exact	RefSeq,		2150/2151 (99 %)	5 diff (99.8 %id)
CV572132	cornea, eye	.f	11 to 271	1 to 261		AAA		261/380 (68 %)	0 diff (100 %id)
CV570672	cornea, eye	.b	2506 to 3129	1 to 624				624/624 (100 %)	0 diff (100 %id)
CV575027	cornea, eye	.b	2385 to 3014	1 to 630				630/630 (100 %)	0 diff (100 %id)
DA811998	ovary, tumor tissue	.b	1384 to 2066	2 to 685		tiling clone, capped		684/684 (100 %)	2 diff (99.8 %id)
DB371264	ovary, tumor tissue	.b	2925 to 3413	490 to 1				490/534 (91 %)	6 diff (98.9 %id)
CR996313	T-Lymphocytes	.vd-u	1 to 376	1 to 377	Q12E	tiling clone,		377/377 (100 %)	3 diff (99.3 %id)
BM760626	lymph node, stomach	.f	29 to 259	1 to 232				232/232 (100 %)	3 diff (98.8 %id)
BM838476	lymph node, stomach	.n	357 to 530	1 to 174				174/174 (100 %)	1 diff (99.5 %id)
BM840566	lymph node, stomach	.o	1 to 410	4 to 413	D89E			413/413 (100 %)	2 diff (99.6 %id)
BM840569	lymph node, stomach	.o	1 to 469	4 to 473	exact			473/473 (100 %)	1 diff (99.8 %id)
BM841161	lymph node, stomach	.o	1 to 523	4 to 526	exact	tiling clone,		526/526 (100 %)	0 diff (100 %id)
BM842394	lymph node, stomach	.o	1 to 517	4 to 520	exact			520/520 (100 %)	0 diff (100 %id)
TI_1948121457		.a	577 to 1163	706 to 119				588/1439 (40 %)	1 diff (100.0 %id)
TI_1948121598		.a	626 to 1163	646 to 109				538/1424 (37 %)	5 diff (99.7 %id)
TI_1948121742		.a	626 to 1163	664 to 124				541/1356 (39 %)	11 diff (99.2 %id)
TI_1948121890		.a	626 to 1163	656 to 118				539/1300 (41 %)	1 diff (100.0 %id)
TI_1948236814		.f	476 to 789	920 to 609			Submitted on the opposite strand	312/1389 (22 %)	12 diff (99.2 %id)
TI_1948236815		.f	475 to 789	923 to 607			Submitted on the opposite strand	317/1401 (22 %)	6 diff (99.6 %id)
TI_1948236818		.f	335 to 789	139 to 593				455/667 (68 %)	10 diff (98.6 %id)
DA968374	stomach	.a	68 to 588	2 to 522		capped		521/556 (93 %)	13 diff (97.7 %id)
DR001533	fetal brain	.a	201 to 866	1 to 665		tiling clone,		667/667 (100 %)	9 diff (98.7 %id)
BE246118	leukopheresis	.b	2503 to 2925	423 to 1				423/423 (100 %)	2 diff (99.6 %id)
BE247265	leukopheresis	.l	1 to 334	1 to 334		tiling clone,		334/334 (100 %)	5 diff (98.6 %id)
BE246810	leukopheresis	.b	2728 to 2925	198 to 1				198/198 (100 %)	1 diff (99.5 %id)
BE247603	leukopheresis	.l	1 to 385	1 to 384	D28V S29L K32N C121W E122G ...	tiling clone,		384/388 (98 %)	8 diff (98.0 %id)
DB015753	esophageal, tumor tissue	.a	171 to 588	2 to 419		capped		418/560 (74 %)	6 diff (99.0 %id)
DB016756	esophageal, tumor tissue	.f	335 to 761	132 to 559		capped		428/559 (76 %)	7 diff (98.8 %id)
DB130913	thymus	.g-u	2774 to 3269	2 to 497		capped		496/496 (100 %)	2 diff (99.6 %id)
DB137564	thymus	.m	1 to 456	2 to 458	F16L V17C T18H E20*	tiling clone, capped		457/457 (100 %)	1 diff (99.8 %id)
DB140287	thymus	.t-u	176 to 646	2 to 472		tiling clone, to resequence, capped		471/471 (100 %)	0 diff (100 %id)
DB345319	thymus	.t-u	3851 to 4405	555 to 1		tiling clone, to resequence,		555/555 (100 %)	2 diff (99.7 %id)
DB142280	thymus	.t-u	1701 to 2227	2 to 528		tiling clone, capped		527/527 (100 %)	1 diff (99.9 %id)
DB143539	thymus	.j	1 to 561	2 to 562	M3V	tiling clone, capped		561/561 (100 %)	1 diff (99.9 %id)
DB147138	thymus	.b	466 to 1002	40 to 577		capped		538/576 (93 %)	7 diff (98.8 %id)
DB156612	thymus	.f	32 to 635	2 to 605		capped		604/604 (100 %)	1 diff (99.9 %id)
TI_149282747		.b	2959 to 3431	40 to 513			Submitted on the opposite strand	474/772 (61 %)	5 diff (99.4 %id)
TI_153988652		.b	3005 to 3431	497 to 71				427/497 (85 %)	0 diff (100 %id)
TI_154032756		.b	2371 to 3180	55 to 863			Submitted on the opposite strand	809/1030 (78 %)	9 diff (99.2 %id)
TI_154143193		.b	2098 to 2670	80 to 654				575/813 (70 %)	13 diff (98.5 %id)
TI_154148720		.c	1064 to 1573	68 to 575				508/575 (88 %)	6 diff (99.0 %id)
TI_154158236		.b	381 to 798	207 to 624				418/550 (76 %)	7 diff (98.8 %id)
DB200794	trachea	.g-u	4827 to 5405	2 to 581		capped		580/580 (100 %)	3 diff (99.5 %id)
DB348331	trachea	.g-u	6786 to 7332	547 to 1				547/547 (100 %)	1 diff (99.9 %id)
DB201322	trachea	.f	1 to 254	2 to 256		capped		255/255 (100 %)	1 diff (99.7 %id)
DB348356	trachea	.f	1333 to 1859	527 to 1				527/527 (100 %)	1 diff (99.9 %id)
BU679924	lung, Primary Lung Epithelial Cells	.b	2961 to 3413	1 to 453		AAA	Submitted on the opposite strand	453/453 (100 %)	1 diff (99.8 %id)
BM672161	eye, human retina	.q	4771 to 5147	377 to 1		fully sequenced,		377/377 (100 %)	3 diff (99.3 %id)
BM700784	eye, human retina	.q	4303 to 4801	1 to 499		fully sequenced,		499/499 (100 %)	5 diff (99.0 %id)
BM664946	eye, optic nerve	.e	646 to 1199	557 to 1		tiling clone, fully sequenced,		557/557 (100 %)	4 diff (99.3 %id)
BM702269	eye, optic nerve	.e	1 to 676	1 to 676		tiling clone, fully sequenced,		676/676 (100 %)	0 diff (100 %id)
BM727230	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.b	703 to 828	1 to 126		fully sequenced,	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	126/126 (100 %)	0 diff (100 %id)
BU740790	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.b	767 to 1347	599 to 19		fully sequenced, AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	581/581 (100 %)	0 diff (100 %id)
BM727644	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.p	1 to 393	1 to 393	exact	tiling clone,		393/485 (81 %)	0 diff (100 %id)
BQ186552	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.b	2580 to 3016	1 to 435		fully sequenced,		435/435 (100 %)	2 diff (99.6 %id)
CK301047	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.b	2986 to 3426	445 to 1		fully sequenced,		445/445 (100 %)	2 diff (99.6 %id)
BM725106	eye, fetal eye	.b	2153 to 2847	1 to 689		fully sequenced,		689/689 (100 %)	5 diff (99.3 %id)
BU742002	eye, fetal eye	.b	2817 to 3187	371 to 1		fully sequenced,		371/371 (100 %)	4 diff (99.0 %id)
CA426173	Bone, Subchondral Bone	.b	2628 to 3282	673 to 19		AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	655/655 (100 %)	0 diff (100 %id)
CA443096	lung, Metastatic Chondrosarcoma	.b	2375 to 3124	1 to 750			Submitted on the opposite strand	750/750 (100 %)	2 diff (99.8 %id)
BQ447277	Knee, Osteoarthritic Cartilage	.b	2382 to 2682	311 to 11		AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	301/307 (98 %)	1 diff (99.7 %id)
BU616558	Cell Line, Chondrosarcoma	.b	2563 to 3282	738 to 19		AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	720/720 (100 %)	1 diff (99.9 %id)
TI_151730791		.b	2579 to 3413	908 to 84		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	825/959 (86 %)	12 diff (98.8 %id)
W22508	eye, retina	.va-u	1 to 512	1 to 505	Q14N H15I K16R E17K V18C ...	tiling clone, AAA		505/614 (82 %)	19 diff (97.0 %id)
AW361805	colon	.b	2455 to 2943	1 to 489				489/489 (100 %)	0 diff (100 %id)
BF954085	nervous_normal	.b	2588 to 3265	1 to 684			This clone was ignored	684/778 (87 %)	14 diff (98.3 %id)
BF956317	nervous_normal	.b	933 to 1340	1 to 408			This clone was ignored	408/408 (100 %)	0 diff (100 %id)
BF957445	nervous_normal	.b	933 to 1340	1 to 408			This clone was ignored	408/408 (100 %)	0 diff (100 %id)
BF958571	nervous_normal	.b	2796 to 3422	634 to 8			This clone was ignored	627/634 (98 %)	0 diff (100 %id)
BF961056	nervous_normal	.b	2796 to 3422	634 to 8			This clone was ignored	627/634 (98 %)	0 diff (100 %id)
BF963520	nervous_normal	.b	933 to 1582	1 to 651			This clone was ignored	651/651 (100 %)	1 diff (99.9 %id)
BQ342872	nervous_normal	.b	933 to 1582	1 to 651			This clone was ignored	651/651 (100 %)	1 diff (99.9 %id)
BQ343087	nervous_normal	.g-u	7023 to 7610	590 to 2			This clone was ignored	589/590 (99 %)	0 diff (100 %id)
BQ343095	nervous_normal	.g-u	7023 to 7610	590 to 2			This clone was ignored	589/590 (99 %)	0 diff (100 %id)
BQ343105	nervous_normal	.b	2386 to 2925	1 to 540			This clone was ignored	540/766 (70 %)	8 diff (99.0 %id)
BQ343162	nervous_normal	.b	2386 to 2925	1 to 540			This clone was ignored	540/766 (70 %)	8 diff (99.0 %id)
BQ343179	nervous_normal	.d	1 to 881	1 to 883		tiling clone,	This clone was ignored	883/884 (99 %)	10 diff (98.9 %id)
BX119310	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.d	1 to 881	1 to 883		tiling clone,		883/884 (99 %)	10 diff (98.9 %id)
CV392082	nervous_normal	.b	466 to 1265	8 to 809			Submitted on the opposite strand	802/862 (93 %)	8 diff (99.1 %id)
FN117082	breast carcinoma	.b	466 to 1265	8 to 809			Submitted on the opposite strand	802/862 (93 %)	8 diff (99.1 %id)
AV700840	hepatocellular carcinoma	.t-u	40 to 960	1 to 926		tiling clone, AAA	Submitted on the opposite strand, submitted on the opposite strand	926/927 (99 %)	19 diff (98.0 %id)
AA678078	liver and spleen	.t-u	40 to 931	1 to 897				897/911 (98 %)	9 diff (99.1 %id)
AA447745	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.b	2386 to 3275	1 to 896				896/900 (99 %)	21 diff (97.7 %id)
AA453676	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.b	2386 to 3275	1 to 896				896/900 (99 %)	21 diff (97.7 %id)
AA601573	pheochromocytoma	.f	599 to 1510	1 to 917				917/922 (99 %)	16 diff (98.3 %id)
AI095223	B-cell, chronic lymphotic leukemia	.f	599 to 1510	1 to 917				917/922 (99 %)	16 diff (98.3 %id)
AI917592	colon, colon tumor, RER+	.b	3327 to 3408	82 to 1			Suspected internal deletion, this clone was ignored	82/82 (100 %)	0 diff (100 %id)
AW297977		.b	3327 to 3408	82 to 1			Suspected internal deletion, this clone was ignored	82/82 (100 %)	0 diff (100 %id)
DB155662	thymus	.b	2386 to 2992	11 to 617		capped		607/617 (98 %)	6 diff (99.1 %id)
DB346460	thymus	.b	2386 to 2992	11 to 617				607/617 (98 %)	6 diff (99.1 %id)
BU852870	testis	.b	2644 to 3409	1 to 777		tiling clone,		777/786 (98 %)	22 diff (97.3 %id)
BU857812	adenocarcinoma, cell line, breast	.c	1 to 770	1 to 772		tiling clone,		772/945 (81 %)	8 diff (99.2 %id)
BU857812	adenocarcinoma, cell line, breast	.c	1 to 770	1 to 772		tiling clone,		772/945 (81 %)	8 diff (99.2 %id)
BU956254	adenocarcinoma, cell line, breast	.u	317 to 939	127 to 753	exact	tiling clone,		627/1025 (61 %)	17 diff (98.4 %id)
BU956254	adenocarcinoma, cell line, breast	.u	317 to 939	127 to 753	exact	tiling clone,		627/1025 (61 %)	17 diff (98.4 %id)
BU956366	adenocarcinoma, cell line, breast	.n	5 to 532	1 to 528				528/536 (98 %)	1 diff (99.9 %id)
BU956366	adenocarcinoma, cell line, breast	.n	5 to 532	1 to 528				528/536 (98 %)	1 diff (99.9 %id)
BU957799	mixed (pool of 40 RNAs)	.b	3115 to 3449	1 to 335				335/335 (100 %)	11 diff (96.8 %id)
CV803181	Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass	.a	185 to 894	1 to 703				703/837 (83 %)	8 diff (99.1 %id)
CV803181	Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass	.a	185 to 894	1 to 703				703/837 (83 %)	8 diff (99.1 %id)
CX758846	Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass	.a	98 to 485	1 to 388			Submitted on the opposite strand	388/779 (49 %)	4 diff (99.5 %id)
CX758846	Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass	.a	98 to 485	1 to 388			Submitted on the opposite strand	388/779 (49 %)	4 diff (99.5 %id)
CB990972	placenta, pre-eclamptic placenta	.b	2369 to 2884	27 to 549				523/912 (57 %)	40 diff (95.7 %id)
CB990972	placenta, pre-eclamptic placenta	.b	2369 to 2884	27 to 549				523/912 (57 %)	40 diff (95.7 %id)
TI_59392879		.b	615 to 966	91 to 443				353/356 (99 %)	2 diff (99.5 %id)
N84905		.b	1125 to 1335	1 to 212				212/212 (100 %)	3 diff (98.6 %id)
CB135005	Liver	.b	2404 to 2948	1 to 545				545/545 (100 %)	1 diff (99.9 %id)
DA655331		.a	87 to 588	2 to 503		capped		502/553 (90 %)	6 diff (99.0 %id)
EB387209	eye, optic nerve	.c	1201 to 2038	1 to 839		tiling clone,		839/839 (100 %)	2 diff (99.8 %id)
EB387209	eye, optic nerve	.c	1201 to 2038	1 to 839		tiling clone,		839/839 (100 %)	2 diff (99.8 %id)
EB388130	eye, optic nerve	.t-u	918 to 1666	1 to 748		tiling clone,		748/748 (100 %)	3 diff (99.6 %id)
EB388130	eye, optic nerve	.t-u	918 to 1666	1 to 748		tiling clone,		748/748 (100 %)	3 diff (99.6 %id)
NM_138962.2		.a	1 to 1581	1 to 1581	exact	RefSeq,		1581/1581 (100 %)	0 diff (100 %id)
NM_170721.1		.f	1 to 2149	2 to 2150	exact	RefSeq,		2150/2151 (99 %)	5 diff (99.8 %id)
CV572132	cornea, eye	.f	11 to 271	1 to 261		AAA		261/380 (68 %)	0 diff (100 %id)
CV572132	cornea, eye	.f	11 to 271	1 to 261		AAA		261/380 (68 %)	0 diff (100 %id)
CV570672	cornea, eye	.b	2506 to 3129	1 to 624				624/624 (100 %)	0 diff (100 %id)
CV570672	cornea, eye	.b	2506 to 3129	1 to 624				624/624 (100 %)	0 diff (100 %id)
CV575027	cornea, eye	.b	2385 to 3014	1 to 630				630/630 (100 %)	0 diff (100 %id)
CV575027	cornea, eye	.b	2385 to 3014	1 to 630				630/630 (100 %)	0 diff (100 %id)
DA811998	ovary, tumor tissue	.b	1384 to 2066	2 to 685		tiling clone, capped		684/684 (100 %)	2 diff (99.8 %id)
DB371264	ovary, tumor tissue	.b	2925 to 3413	490 to 1				490/534 (91 %)	6 diff (98.9 %id)
CR996313	T-Lymphocytes	.vd-u	1 to 376	1 to 377	Q12E	tiling clone,		377/377 (100 %)	3 diff (99.3 %id)
BM760626	lymph node, stomach	.f	29 to 259	1 to 232				232/232 (100 %)	3 diff (98.8 %id)
BM760626	lymph node, stomach	.f	29 to 259	1 to 232				232/232 (100 %)	3 diff (98.8 %id)
BM838476	lymph node, stomach	.n	357 to 530	1 to 174				174/174 (100 %)	1 diff (99.5 %id)
BM838476	lymph node, stomach	.n	357 to 530	1 to 174				174/174 (100 %)	1 diff (99.5 %id)
BM840566	lymph node, stomach	.o	1 to 410	4 to 413	D89E			413/413 (100 %)	2 diff (99.6 %id)
BM840566	lymph node, stomach	.o	1 to 410	4 to 413	D89E			413/413 (100 %)	2 diff (99.6 %id)
BM840569	lymph node, stomach	.o	1 to 469	4 to 473	exact			473/473 (100 %)	1 diff (99.8 %id)
BM840569	lymph node, stomach	.o	1 to 469	4 to 473	exact			473/473 (100 %)	1 diff (99.8 %id)
BM841161	lymph node, stomach	.o	1 to 523	4 to 526	exact	tiling clone,		526/526 (100 %)	0 diff (100 %id)
BM841161	lymph node, stomach	.o	1 to 523	4 to 526	exact	tiling clone,		526/526 (100 %)	0 diff (100 %id)
BM842394	lymph node, stomach	.o	1 to 517	4 to 520	exact			520/520 (100 %)	0 diff (100 %id)
BM842394	lymph node, stomach	.o	1 to 517	4 to 520	exact			520/520 (100 %)	0 diff (100 %id)
TI_1948121457		.a	577 to 1163	706 to 119				588/1439 (40 %)	1 diff (100.0 %id)
TI_1948121598		.a	626 to 1163	646 to 109				538/1424 (37 %)	5 diff (99.7 %id)
TI_1948121742		.a	626 to 1163	664 to 124				541/1356 (39 %)	11 diff (99.2 %id)
TI_1948121890		.a	626 to 1163	656 to 118				539/1300 (41 %)	1 diff (100.0 %id)
TI_1948236814		.f	476 to 789	920 to 609			Submitted on the opposite strand	312/1389 (22 %)	12 diff (99.2 %id)
TI_1948236815		.f	475 to 789	923 to 607			Submitted on the opposite strand	317/1401 (22 %)	6 diff (99.6 %id)
TI_1948236818		.f	335 to 789	139 to 593				455/667 (68 %)	10 diff (98.6 %id)
DA968374	stomach	.a	68 to 588	2 to 522		capped		521/556 (93 %)	13 diff (97.7 %id)
DR001533	fetal brain	.a	201 to 866	1 to 665		tiling clone,		667/667 (100 %)	9 diff (98.7 %id)
BE246118	leukopheresis	.b	2503 to 2925	423 to 1				423/423 (100 %)	2 diff (99.6 %id)
BE247265	leukopheresis	.l	1 to 334	1 to 334		tiling clone,		334/334 (100 %)	5 diff (98.6 %id)
BE246810	leukopheresis	.b	2728 to 2925	198 to 1				198/198 (100 %)	1 diff (99.5 %id)
BE247603	leukopheresis	.l	1 to 385	1 to 384	D28V S29L K32N C121W E122G ...	tiling clone,		384/388 (98 %)	8 diff (98.0 %id)
DB015753	esophageal, tumor tissue	.a	171 to 588	2 to 419		capped		418/560 (74 %)	6 diff (99.0 %id)
DB016756	esophageal, tumor tissue	.f	335 to 761	132 to 559		capped		428/559 (76 %)	7 diff (98.8 %id)
DB130913	thymus	.g-u	2774 to 3269	2 to 497		capped		496/496 (100 %)	2 diff (99.6 %id)
DB137564	thymus	.m	1 to 456	2 to 458	F16L V17C T18H E20*	tiling clone, capped		457/457 (100 %)	1 diff (99.8 %id)
DB140287	thymus	.t-u	176 to 646	2 to 472		tiling clone, to resequence, capped		471/471 (100 %)	0 diff (100 %id)
DB345319	thymus	.t-u	3851 to 4405	555 to 1		tiling clone, to resequence,		555/555 (100 %)	2 diff (99.7 %id)
DB142280	thymus	.t-u	1701 to 2227	2 to 528		tiling clone, capped		527/527 (100 %)	1 diff (99.9 %id)
DB143539	thymus	.j	1 to 561	2 to 562	M3V	tiling clone, capped		561/561 (100 %)	1 diff (99.9 %id)
DB147138	thymus	.b	466 to 1002	40 to 577		capped		538/576 (93 %)	7 diff (98.8 %id)
DB156612	thymus	.f	32 to 635	2 to 605		capped		604/604 (100 %)	1 diff (99.9 %id)
TI_149282747		.b	2959 to 3431	40 to 513			Submitted on the opposite strand	474/772 (61 %)	5 diff (99.4 %id)
TI_153988652		.b	3005 to 3431	497 to 71				427/497 (85 %)	0 diff (100 %id)
TI_154032756		.b	2371 to 3180	55 to 863			Submitted on the opposite strand	809/1030 (78 %)	9 diff (99.2 %id)
TI_154143193		.b	2098 to 2670	80 to 654				575/813 (70 %)	13 diff (98.5 %id)
TI_154148720		.c	1064 to 1573	68 to 575				508/575 (88 %)	6 diff (99.0 %id)
TI_154158236		.b	381 to 798	207 to 624				418/550 (76 %)	7 diff (98.8 %id)
DB200794	trachea	.g-u	4827 to 5405	2 to 581		capped		580/580 (100 %)	3 diff (99.5 %id)
DB348331	trachea	.g-u	6786 to 7332	547 to 1				547/547 (100 %)	1 diff (99.9 %id)
DB201322	trachea	.f	1 to 254	2 to 256		capped		255/255 (100 %)	1 diff (99.7 %id)
DB348356	trachea	.f	1333 to 1859	527 to 1				527/527 (100 %)	1 diff (99.9 %id)
BU679924	lung, Primary Lung Epithelial Cells	.b	2961 to 3413	1 to 453		AAA	Submitted on the opposite strand	453/453 (100 %)	1 diff (99.8 %id)
BU679924	lung, Primary Lung Epithelial Cells	.b	2961 to 3413	1 to 453		AAA	Submitted on the opposite strand	453/453 (100 %)	1 diff (99.8 %id)
BM672161	eye, human retina	.q	4771 to 5147	377 to 1		fully sequenced,		377/377 (100 %)	3 diff (99.3 %id)
BM672161	eye, human retina	.q	4771 to 5147	377 to 1		fully sequenced,		377/377 (100 %)	3 diff (99.3 %id)
BM700784	eye, human retina	.q	4303 to 4801	1 to 499		fully sequenced,		499/499 (100 %)	5 diff (99.0 %id)
BM700784	eye, human retina	.q	4303 to 4801	1 to 499		fully sequenced,		499/499 (100 %)	5 diff (99.0 %id)
BM664946	eye, optic nerve	.e	646 to 1199	557 to 1		tiling clone, fully sequenced,		557/557 (100 %)	4 diff (99.3 %id)
BM664946	eye, optic nerve	.e	646 to 1199	557 to 1		tiling clone, fully sequenced,		557/557 (100 %)	4 diff (99.3 %id)
BM702269	eye, optic nerve	.e	1 to 676	1 to 676		tiling clone, fully sequenced,		676/676 (100 %)	0 diff (100 %id)
BM702269	eye, optic nerve	.e	1 to 676	1 to 676		tiling clone, fully sequenced,		676/676 (100 %)	0 diff (100 %id)
BM727230	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.b	703 to 828	1 to 126		fully sequenced,	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	126/126 (100 %)	0 diff (100 %id)
BM727230	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.b	703 to 828	1 to 126		fully sequenced,	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	126/126 (100 %)	0 diff (100 %id)
BU740790	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.b	767 to 1347	599 to 19		fully sequenced, AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	581/581 (100 %)	0 diff (100 %id)
BU740790	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.b	767 to 1347	599 to 19		fully sequenced, AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	581/581 (100 %)	0 diff (100 %id)
BM727644	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.p	1 to 393	1 to 393	exact	tiling clone,		393/485 (81 %)	0 diff (100 %id)
BM727644	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.p	1 to 393	1 to 393	exact	tiling clone,		393/485 (81 %)	0 diff (100 %id)
BQ186552	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.b	2580 to 3016	1 to 435		fully sequenced,		435/435 (100 %)	2 diff (99.6 %id)
BQ186552	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.b	2580 to 3016	1 to 435		fully sequenced,		435/435 (100 %)	2 diff (99.6 %id)
CK301047	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.b	2986 to 3426	445 to 1		fully sequenced,		445/445 (100 %)	2 diff (99.6 %id)
CK301047	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.b	2986 to 3426	445 to 1		fully sequenced,		445/445 (100 %)	2 diff (99.6 %id)
BM725106	eye, fetal eye	.b	2153 to 2847	1 to 689		fully sequenced,		689/689 (100 %)	5 diff (99.3 %id)
BM725106	eye, fetal eye	.b	2153 to 2847	1 to 689		fully sequenced,		689/689 (100 %)	5 diff (99.3 %id)
BU742002	eye, fetal eye	.b	2817 to 3187	371 to 1		fully sequenced,		371/371 (100 %)	4 diff (99.0 %id)
BU742002	eye, fetal eye	.b	2817 to 3187	371 to 1		fully sequenced,		371/371 (100 %)	4 diff (99.0 %id)
CA426173	Bone, Subchondral Bone	.b	2628 to 3282	673 to 19		AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	655/655 (100 %)	0 diff (100 %id)
CA426173	Bone, Subchondral Bone	.b	2628 to 3282	673 to 19		AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	655/655 (100 %)	0 diff (100 %id)
CA443096	lung, Metastatic Chondrosarcoma	.b	2375 to 3124	1 to 750			Submitted on the opposite strand	750/750 (100 %)	2 diff (99.8 %id)
CA443096	lung, Metastatic Chondrosarcoma	.b	2375 to 3124	1 to 750			Submitted on the opposite strand	750/750 (100 %)	2 diff (99.8 %id)
BQ447277	Knee, Osteoarthritic Cartilage	.b	2382 to 2682	311 to 11		AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	301/307 (98 %)	1 diff (99.7 %id)
BQ447277	Knee, Osteoarthritic Cartilage	.b	2382 to 2682	311 to 11		AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	301/307 (98 %)	1 diff (99.7 %id)
BU616558	Cell Line, Chondrosarcoma	.b	2563 to 3282	738 to 19		AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	720/720 (100 %)	1 diff (99.9 %id)
BU616558	Cell Line, Chondrosarcoma	.b	2563 to 3282	738 to 19		AAA	Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base)	720/720 (100 %)	1 diff (99.9 %id)
TI_151730791		.b	2579 to 3413	908 to 84		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	825/959 (86 %)	12 diff (98.8 %id)
W22508	eye, retina	.va-u	1 to 512	1 to 505	Q14N H15I K16R E17K V18C ...	tiling clone, AAA		505/614 (82 %)	19 diff (97.0 %id)
W22508	eye, retina	.va-u	1 to 512	1 to 505	Q14N H15I K16R E17K V18C ...	tiling clone, AAA		505/614 (82 %)	19 diff (97.0 %id)